ArticleFrontiers in veterinary science2025
Semiquantitative acid-base analysis in hypokalemic dogs with immune-mediated hemolytic anemia.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe and compare the traditional and semiquantitative acid-base status of dogs with immune-mediated hemolytic anemia (IMHA) and hypokalemia to those with normokalemia. Methods: Medical records of dogs with IMHA from a single institution over a 10-year period from January 1st, 2012 to December 31st, 2021 were retrospectively reviewed. Dogs were included if they met diagnostic criteria for IMHA based on the 2019 ACVIM consensus guidelines and had at least 1 blood potassium concentration measurement performed within 24 h of initial presentation. The dogs were divided into normokalemic and hypokalemic groups. Hypokalemia was categorized as mild (3-3.5 mEq/L [3-3.5 mmmol/L]), moderate (2-2.9 mEq/L [2-2.9 mmol/L]), or severe (<2 mEq/L [<2 mmol/L]). Population data, clinicopathologic data, and outcome were collected and recorded. Traditional and semiquantitative acid-base diagnoses were attributed to patients with sufficient data. Results: 305 client-owned dogs with IMHA met the inclusion criteria. 186 dogs (61.0%) were normokalemic and 119 (39.0%) were hypokalemic (blood potassium concentration ≤ 3.5 mEq/L [≤ 3.5 mmol/L]) on presentation. The median blood potassium concentration in the hypokalemic group was 3.2 mEq/L (3.2 mmol/L) (interquartile range: 2.8-3.4 mEq/L [2.8-3.4 mmol/L]). Hypokalemia was mild in 78/119 (65.5%) dogs, moderate in 40/119 (33.6%) and severe in 1/119 (0.84%) cases. Metabolic acidosis was the most common traditional acid-base disorder identified in both normokalemic (26/82, 31.7%) and hypokalemic (44/92, 47.8%) dogs but the proportion was significantly higher in the hypokalemic group ( Conclusion: Hypokalemia is common in dogs with IMHA within the first 24 h of presentation and is associated with a variety of acid-base abnormalities. Hypokalemic dogs with IMHA appear more likely to develop metabolic acidosis and less likely to survive to hospital discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.